Effect of HPI on kidney injury after robotic urological surgery
Effect of Use of Hypotension Prediction System in Prevention of Postoperative Acute Kidney Injury in Robotic-assisted Urologic Surgery
This study is testing if using a special software to predict low blood pressure during robot-assisted urological surgeries can help prevent kidney damage in patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 124 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Ewha Womans University Mokdong Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06051162 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the impact of the hypotension prediction index (HPI) on preventing acute kidney injury (AKI) following robot-assisted urological surgeries. It is a single-center randomized controlled trial that aims to determine whether HPI software guidance can reduce the duration and severity of intraoperative hypotension, which is believed to contribute to postoperative AKI. Patients aged 19 and older undergoing such surgeries will be enrolled to assess the effectiveness of this intervention.
Who should consider this trial
Good fit: Ideal candidates are patients aged 19 and older who are scheduled for robot-assisted urological surgery.
Not a fit: Patients who are unable to give voluntary consent or have specific contraindications related to radial artery access may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of acute kidney injury in patients undergoing robotic urological surgeries.
How similar studies have performed: While the specific application of HPI in this context may be novel, similar approaches in managing intraoperative hypotension have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≧ 19 * Patients undergoing robot-assisted urological surgery Exclusion Criteria: * Unable to voluntarily give consent * Unable to use both radial arteries due to such reasons: prior surgery on the radial artery, breast cancer history with axillary LN dissection, AV fistula for renal replacement therapy, or abnormal Allen's test.
Where this trial is running
Seoul
- Ewha Womans University Mokdong Hospital — Seoul, Korea, Republic of (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.